Previous 10 | Next 10 |
Agreement expands patient access to SINUVA treatment with announcement of third partnership with a specialty pharmacy Intersect ENT, Inc. (Nasdaq: XENT), a company transforming care for patients with ear, nose and throat (ENT) conditions, today announced that it has executed a pharmac...
Intersect ENT, Inc. (XENT) Q2 2020 Results Earnings Conference Call August 04, 2020, 08:30 AM ET Company Participants Richard Meier - Executive VP & CFO Thomas West - President & CEO Conference Call Participants Chris Pasquale - Guggenheim Ravi Misra - Berenberg S...
Intersect ENT (NASDAQ: XENT ) : Q2 Non-GAAP EPS of -$0.65 misses by $0.09 ; GAAP EPS of -$0.71 misses by $0.13 . More news on: Intersect ENT, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
Intersect ENT, Inc. (Nasdaq: XENT), a company transforming care for patients with ear, nose and throat (“ENT”) conditions, today reported financial results for the second quarter ended June 30, 2020. Second Quarter 2020 Overview Revenue of $9.8 million in the second ...
Intersect ENT, Inc. (Nasdaq: XENT), a company transforming care for patients with ear, nose and throat (“ENT”) conditions, today announced that it will release second quarter 2020 financial results on August 4, 2020. The Company expects to issue the release at approximately 7:00...
Original post Editor's Note : The summary bullets for this article were chosen by Seeking Read more ...
Gainers: Senmiao Technology (NASDAQ: AIHS ) +71% . More news on: Senmiao Technology Limited, National General Holdings Corp., Tantech Holdings Ltd, Stocks on the move, , Read more ...
Shares of Intersect ENT (NASDAQ: XENT) were skyrocketing 29.6% higher as of 11:13 a.m. EDT on Wednesday. The big jump came after Bloomberg reported that medical device giant Medtronic (NYSE: MDT) made an offer to acquire Intersect. No terms of the potential acquisition were disclo...
National General Holdings (NASDAQ: NGHC ) +66% on being acquired by Allstate. More news on: National General Holdings Corp., NanoViricides, Inc., Intersect ENT, Inc., Stocks on the move, , Read more ...
According to informed sources, Medtronic (NYSE: MDT ) has made an offer for sinus implant developer Intersect ENT (NASDAQ: XENT ). More news on: Medtronic plc, Intersect ENT, Inc., Healthcare stocks news, Stocks on the move, Merger & acquisition news, Read more ...
News, Short Squeeze, Breakout and More Instantly...
Data from first-of-its-kind study published in Current Medical Research and Opinion Patients receiving PROPEL ® following endoscopic sinus surgery had statistically significant lower healthcare resource utilization over a postoperative period of 18 months, including a...
Intersect ENT, Inc. (Nasdaq: XENT), a global ear, nose and throat (“ENT”) medical technology leader dedicated to transforming patient care, today reported financial results for the third quarter ended September 30, 2021. Total revenue was $24.4 million for the third qu...
Intersect ENT®, Inc. (Nasdaq: XENT), a global ear, nose and throat (“ENT”) medical technology leader dedicated to transforming patient care, today announced that Helios Dr. Horst Schmidt Kliniken Wiesbaden in Germany was the first hospital outside the United States to...